Controlled trial of antithrombin III supplementation in fulminant hepatic failure
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 17 (3) , 326-331
- https://doi.org/10.1016/s0168-8278(05)80213-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Thrombin—antithrombin III complex in fulminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcomeEuropean Journal of Clinical Investigation, 1990
- Early indicators of prognosis in fulminant hepatic failureGastroenterology, 1989
- Antithrombin III concentrate in the treatment of fulminant hepatic failureGastroenterologia Japonica, 1988
- Cardiovascular, Pulmonary and Renal Complications of Fulminant Hepatic FailureSeminars in Liver Disease, 1986
- Tissue hypoxia during fulminant hepatic failureCritical Care Medicine, 1985
- Substitution of antithrombin III in shock and DIC: A randomized studyThrombosis Research, 1985
- Fibrinogen derivatives and platelet activation products in acute and chronic liver diseaseClinical Science, 1985
- Platelet Adhesiveness to Glass Beads in Liver DiseaseActa Haematologica, 1982
- Acute hepatic necrosis and fulminant hepatic failure.Gut, 1973
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957